Alyeska Investment Group, L.P. - IMPAX LABORATORIES INC ownership

IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 196 filers reported holding IMPAX LABORATORIES INC in Q3 2015. The put-call ratio across all filers is 2.02 and the average weighting 0.4%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of IMPAX LABORATORIES INC
ValueSharesWeighting
Q4 2017$18,732,000
+97.8%
1,125,047
+141.2%
0.15%
+109.9%
Q3 2017$9,470,000
-62.3%
466,515
-56.0%
0.07%
-69.5%
Q3 2016$25,146,000
-42.8%
1,061,001
-30.4%
0.23%
-43.6%
Q2 2016$43,965,000
+12.6%
1,525,505
+25.1%
0.41%
+15.0%
Q1 2016$39,035,000
-25.2%
1,219,074
-0.1%
0.36%
-35.3%
Q4 2015$52,191,000
+96.6%
1,220,553
+61.9%
0.56%
+77.9%
Q3 2015$26,551,000754,0890.31%
Other shareholders
IMPAX LABORATORIES INC shareholders Q3 2015
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 560,400$9,022,0003.93%
NORTH TIDE CAPITAL, LLC 1,000,000$16,100,0003.58%
Sivik Global Healthcare LLC 250,000$4,025,0001.47%
MAVERICK CAPITAL LTD 7,159,336$115,265,0001.44%
SECTOR GAMMA AS 589,311$9,488,0001.38%
BRIDGER MANAGEMENT, LLC 1,341,143$21,592,0001.23%
Eos Focused Equity Management, L.P. 48,714$784,0000.89%
Bridge City Capital, LLC 47,194$760,0000.64%
Fosun International Ltd 300,000$4,830,0000.60%
Century Capital Management, LLC 203,138$3,271,0000.56%
View complete list of IMPAX LABORATORIES INC shareholders